Conavi Medical, Inc.

Conavi Medical, Inc. has 1 AI-enabled medical device on the FDA list. The first decision was on April 17, 2026 and the most recent on April 17, 2026 (Novasight Hybrid System). Its most common review panel is Cardiovascular (1 device).